Ebola

Name:
Instructor:
Course:
Date:
Ebola
The Ebola virus is contended to be one of the most dreadful viruses to ever originate from the African subcontinent. Notably, it was first noticed in 1976, and it is morphologically related to the Marburg disease. The main signs, as well as symptoms of Ebola, usually commence with fever, muscle pain as well as a sore throat. It is important to note that they are capable of escalating quickly into vomiting, diarrhea and both internal and external bleeding. The symptoms may be noticeable between 2 to 21 days after the infection. However, the typical period of incubation ranges from 8 to 10 days. Before the disease develops into the bleeding level, the signs can be related to those of common diseases such as malaria, dengue fever among other tropical fevers. As the infection of Ebola continues, there are severe complications such as kidney and liver dysfunction, dehydration, as well as hemorrhage. Among pregnant ladies, Ebola may lead to spontaneous abortion, disseminated intravascular coagulation, azotemia, and massive hemorrhage.
Today, there are no vaccines or cures for Ebola. Therefore, there is a need for every case to be tested with the highest possible level of biohazard protection to avoid more infections. According to Vidal (123), the currently approved treatments for Ebola do not guarantee survival, though early treatment increases the chances of survival. The treatment if often founded on supportive nature, focusing mainly on rehydration as well as symptomatic treatment.

The symptomatic treatment entails measures to regulate pain, anxiety, fever and nausea. The victims ought to be rehydrated through oral or arterial route. Few strategies are being applied in the containment of Ebola. One significant method is the constant tracing which entails tracing down every individual who has had close contact with the Ebola virus or any Ebola case for three weeks. Notably, this requires close recording by highly trained staff. Moreover, there are travel restrictions as well as quarantines that are being applied to the particular areas of Africa where the virus is heavily present.
Additionally, the Ebola virus disease presents significant clinical implications for the pharmacists. Therefore, emergency efforts should be initiated to ensure spirited response to Ebola. The pharmacists ought to consider various factors including the utilization of resources for front-line Ebola victim care along with procurement of various investigational medications (Matowe). Moreover, adequate and relevant distribution, as well as administration of treatment for patients with Ebola in the setting of substantial, vital illness and infection control regulations, are also important.
Conclusively, in those affected regions in Africa, particularly in the Western parts, there have been reviewed reaction that builds on past instances. Most responders have been trained to acknowledge the significance of tailoring the reaction methods to complement the separate requirements at the district level and also the sub-district level. Moreover, a clear comprehension of the conduction changes at the rural level commonly asserts that control methods are functioning successfully and those that may need improvements. There prevention of outbreaks in the unaffected countries considering the number of cases as well as infected prefectures in Guinea-Bissau. Therefore, about readiness, the most crucial necessity entails real scrutiny in areas such as Mali, Senegal, and other neighboring countries. This can be by hiring more personnel and increasing the resource materials. Standard performance, monitoring, and reporting in structured periods is also essential.

References
Matowe, Lloyd. “Pharmacy Can Help Fight Against Ebola”. Pharmaceutical Journal, 2016, http://www.pharmaceutical-journal.com/opinion/comment/pharmacy-can-help-fight-against-ebola/20066289.article.
Vidal, Yinka. How To Prevent The Spread Of Ebola: Effective Strategies To Reduce Hospital Acquired Infections. 1st ed., Lara Publications Inc, 2015.